- Report of Foreign Issuer (6-K)
13 11월 2012 - 8:04PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of November 2012
Commission File Number: 001-34225
VIMICRO INTERNATIONAL CORPORATION
15/F Shining Tower
No. 35 Xueyuan Road, Haidian District
Beijing 100191, Peoples Republic of China
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
o
This Form 6-K is being incorporated by reference into the registrants Registration Statement on Form S-3 (File No. 333-166948), filed with the Securities and Exchange Commission on May 19, 2010.
Third-Quarter 2012 Results
Vimicro International Corporation (Vimicro or the Company) reports its unaudited financial
results for the third quarter ended September 30, 2012
.
Net revenue in the third quarter of 2012 was $21.7 million, as compared to net revenue from continuing operations of $19.5 million in the second quarter and $18.9 million from continuing operations in the year-ago quarter. (Results for the
third quarter of
201
1 and the second and third quarters
of
2012
have been
adjusted
to reflect the divestiture
of certain business lines
.) The 14.9% year-over-year revenue increase was due to an increase in sales in both product lines, reflecting more managerial and operating resources allocated to our continuing operations after the business disposals.
Gross profit in the third quarter was $8.3 million, as compared with $6.0 million in the year-ago quarter. The gross margin in the third quarter was 38.0%, as compared with 31.
8
% in the year-ago quarter and 36.5% in the second quarter, reflecting higher gross margin yielded from some new products.
Operating expenses in the third quarter were $6.8 million, as compared to $11.3 million in the year-ago quarter. Operating expenses decreased year-over-year, due to the Companys
divestiture of under-performing businesses
and an increase in focus on its two continuing business lines. The Company recorded an operating income of $1.5 million, as compared to a loss of $5.3 million in the year-ago quarter.
Vimicro remained profitable on a non-GAAP basis in the third quarter, and non-GAAP net
income from continuing operations
attributable to Vimicro International Corporation was $
2.9 million
, or approximately $0.09 per
ADS
on a diluted basis
, as compared to a non-GAAP net loss from continuing operations attributable to Vimicro of $
1.7
million, or $0.05 per ADS in the year-ago quarter. The non-GAAP net income attributable to Vimicro International Corporation excludes $0.4 million of non-cash, share-based compensation. In the third quarter, Vimicro recorded a net income attributable to Vimicro of $2.9 million, or $0.
10
per ADS on a diluted basis, as compared to a loss of $
5
.3 million, or $0.
14
per ADS
in the year-ago quarter
.
As of September 30, 2012, the Company had cash and cash equivalents of approximately $33.2 million and restricted cash of $5.2 million, totaling $38.4 million. Total current assets were approximately $
91.8
million. Vimicro had a working capital of approximately $
64.7
million, and long-term bank loans of $4.7 million on its balance sheet, as of September 30, 2012.
2
Non-GAAP Measures
To supplement the consolidated financial statements presented in accordance with GAAP, Vimicro uses non-GAAP measures of non-GAAP income/(loss) from operations, non-GAAP net income/(loss) attributed to Vimicro International Corporation and non-GAAP diluted net income /(loss) from continuing operations per ADS, which are adjusted from the most directly comparable financial measures calculated and presented in accordance with GAAP to exclude amortization of share-based compensation expense. These non-GAAP financial measures are provided to enhance investors overall understanding of the Companys financial performance as they exclude share-based expenses that are not expected to result in future cash payments. The non-GAAP measures should be considered in addition to results prepared in accordance with GAAP, but should not be considered a substitute for or superior to GAAP results. A limitation of using these non-GAAP financial measures is that these non-GAAP measures exclude share-based compensation charges that have been and will continue to be significant recurring expenses in our business for the foreseeable future. We compensate for these limitations by providing the relevant disclosure of our share-based compensation charges in our reconciliations to the GAAP measures. For more information on the non-GAAP financial measures, please see the tables captioned Reconciliation of non- GAAP results of operations measures to the nearest comparable GAAP measures set forth at the end of this release.
Vimicro believes that both management and investors benefit from referring to these non-GAAP measures in assessing the performance of Vimicros liquidity and when planning and forecasting future periods. These non-GAAP financial measures also facilitate managements internal comparisons to Vimicros historical liquidity. Vimicro computes its non-GAAP financial measures using the same consistent method from quarter to quarter. The accompanying tables have more details on the GAAP financial measures that are most comparable to non-GAAP financial measures and the related reconciliations between financial measures.
Currency Translation
This announcement contains translations of certain RMB amounts into U.S. dollars. Unless otherwise noted, all translations from RMB to U.S. dollars are based on the applicable exchange rates quoted by the Bank of China, which was RMB 6.3410 to $1.00 on September 28, 2012.
3
Vimicro International Corporation
Consolidated Balance Sheets
(Amounts expressed in thousands of U.S. dollars, except number of shares data)
|
|
9/30/2012
|
|
12/31/2011
|
|
|
|
(unaudited)
|
|
(audited)
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
Cash and cash equivalents
|
|
33,192
|
|
49,227
|
|
Restricted cash
|
|
5,201
|
|
3,520
|
|
Accounts and notes receivable, net of provision for doubtful accounts of $2,070 and $1,822 as of September 30, 2012 and December 31, 2011, respectively
|
|
23,126
|
|
17,895
|
|
Amounts due from related party
|
|
7,580
|
|
4,831
|
|
Inventories
|
|
12,886
|
|
18,734
|
|
Prepayments and other current assets, net of provision for doubtful accounts of $305 and $162 as of September 30, 2012 and December 31, 2011, respectively
|
|
2,994
|
|
4,057
|
|
Asset held-for-sale
|
|
6,474
|
|
0
|
|
Deferred tax assets
|
|
357
|
|
356
|
|
Total current assets
|
|
91,810
|
|
98,620
|
|
Investment in an unconsolidated affiliate
|
|
5,612
|
|
1,520
|
|
Property, equipment and software, net
|
|
16,337
|
|
14,266
|
|
Land use rights
|
|
14,675
|
|
21,488
|
|
Deferred tax assets-non current
|
|
112
|
|
112
|
|
Other assets
|
|
1,535
|
|
1,291
|
|
Total assets
|
|
130,081
|
|
137,297
|
|
|
|
|
|
|
|
Liabilities and Equity
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
5,111
|
|
9,280
|
|
Notes payable
|
|
0
|
|
1,013
|
|
Amounts due to related party
|
|
672
|
|
963
|
|
Taxes payable
|
|
2,835
|
|
1,209
|
|
Advances from customers
|
|
230
|
|
1,916
|
|
Accrued expenses and other current liabilities
|
|
8,436
|
|
8,333
|
|
Deferred government grant
|
|
9,841
|
|
5,910
|
|
Total current liabilities
|
|
27,125
|
|
28,624
|
|
Non-current liabilities:
|
|
|
|
|
|
Deferred tax liabilities
|
|
33
|
|
33
|
|
Product warranty
|
|
424
|
|
300
|
|
Long-term bank loan
|
|
4,731
|
|
0
|
|
Total liabilities
|
|
32,313
|
|
28,957
|
|
|
|
|
|
|
|
Commitments and contingencies
|
|
|
|
|
|
|
|
|
|
|
|
Equity:
|
|
|
|
|
|
Ordinary shares,$0.0001 par value, 500,000,000 shares authorized, 118,231,636 and 139,953,296 shares issued and outstanding as of September 30, 2012 and December 31, 2011, respectively
|
|
15
|
|
15
|
|
Additional paid-in capital
|
|
160,612
|
|
158,879
|
|
Treasury stock
|
|
(13,254
|
)
|
(6,490
|
)
|
Accumulated other comprehensive income
|
|
12,695
|
|
12,850
|
|
Accumulated deficit
|
|
(83,704
|
)
|
(82,630
|
)
|
Statutory reserve
|
|
2,782
|
|
2,782
|
|
Total equity attributable to Vimicro International Corporation
|
|
79,146
|
|
85,406
|
|
Non-controlling interest
|
|
18,622
|
|
22,934
|
|
Total equity
|
|
97,768
|
|
108,340
|
|
|
|
|
|
|
|
Total liabilities and equity
|
|
130,081
|
|
137,297
|
|
4
Vimicro International Corporation
Consolidated Statement Of Comprehensive Income/ (loss)
(Amounts expressed in thousands of U.S. dollars, except number of shares and per share data)
|
|
2012 Q3
|
|
2012 Q2
|
|
2011 Q3
|
|
|
|
(unaudited)
|
|
(unaudited)
|
|
(unaudited)
|
|
|
|
|
|
|
|
|
|
Net revenue
|
|
21,748
|
|
19,519
|
|
18,921
|
|
|
|
|
|
|
|
|
|
Cost of revenue
|
|
(13,490
|
)
|
(12,404
|
)
|
(12,905
|
)
|
|
|
|
|
|
|
|
|
Gross profit
|
|
8,258
|
|
7,115
|
|
6,016
|
|
|
|
|
|
|
|
|
|
Operating expenses:
|
|
|
|
|
|
|
|
Research and development, net
|
|
(1,840
|
)
|
(2,842
|
)
|
(5,308
|
)
|
Selling and marketing
|
|
(2,484
|
)
|
(2,159
|
)
|
(3,261
|
)
|
General and administrative
|
|
(2,452
|
)
|
(3,047
|
)
|
(2,758
|
)
|
Total operating expenses
|
|
(6,776
|
)
|
(8,048
|
)
|
(11,327
|
)
|
Income/(loss) from operations
|
|
1,482
|
|
(933
|
)
|
(5,311
|
)
|
|
|
|
|
|
|
|
|
Other income:
|
|
|
|
|
|
|
|
Interest income
|
|
3
|
|
125
|
|
210
|
|
Foreign exchange gain/(loss), net
|
|
(87
|
)
|
(159
|
)
|
617
|
|
Others, net
|
|
1
|
|
1
|
|
5
|
|
|
|
|
|
|
|
|
|
Income/ (loss) before income taxes and share of profit/ (loss) of an unconsolidated affiliates
|
|
1,399
|
|
(966
|
)
|
(4,479
|
)
|
|
|
|
|
|
|
|
|
Income tax (expense)/ beneifit
|
|
(227
|
)
|
(175
|
)
|
37
|
|
|
|
|
|
|
|
|
|
Net income/ (loss) before share of profit/ (loss) of an unconsolidated affiliates
|
|
1,172
|
|
(1,141
|
)
|
(4,442
|
)
|
|
|
|
|
|
|
|
|
Net income/ (loss) from continuing operations
|
|
1,172
|
|
(1,141
|
)
|
(4,442
|
)
|
|
|
|
|
|
|
|
|
Income/ (loss) from discontinued operations, net of income tax
|
|
494
|
|
(699
|
)
|
(2,920
|
)
|
|
|
|
|
|
|
|
|
Net income/ (loss)
|
|
1,666
|
|
(1,840
|
)
|
(7,362
|
)
|
|
|
|
|
|
|
|
|
Loss attributable to non-controlling interest
|
|
(1,277
|
)
|
(1,497
|
)
|
(2,096
|
)
|
|
|
|
|
|
|
|
|
Income/ (loss) attributed to Vimicro International Corporation
|
|
2,943
|
|
(343
|
)
|
(5,266
|
)
|
|
|
|
|
|
|
|
|
Income/ (loss) per share
|
|
|
|
|
|
|
|
continuing operations
|
|
|
|
|
|
|
|
Basic
|
|
0.02
|
|
0.00
|
|
(0.02
|
)
|
Diluted
|
|
0.02
|
|
0.00
|
|
(0.02
|
)
|
discontinued operations
|
|
|
|
|
|
|
|
Basic
|
|
0.00
|
|
0.00
|
|
(0.02
|
)
|
Diluted
|
|
0.00
|
|
0.00
|
|
(0.02
|
)
|
Income/ (loss) per share
|
|
|
|
|
|
|
|
Basic
|
|
0.02
|
|
(0.00
|
)
|
(0.04
|
)
|
Diluted
|
|
0.02
|
|
(0.00
|
)
|
(0.04
|
)
|
|
|
|
|
|
|
|
|
Income/ (loss) per ADS
|
|
|
|
|
|
|
|
continuing operations
|
|
|
|
|
|
|
|
Basic
|
|
0.08
|
|
0.01
|
|
(0.06
|
)
|
Diluted
|
|
0.08
|
|
0.01
|
|
(0.06
|
)
|
discontinued operations
|
|
|
|
|
|
|
|
Basic
|
|
0.02
|
|
(0.02
|
)
|
(0.08
|
)
|
Diluted
|
|
0.02
|
|
(0.02
|
)
|
(0.08
|
)
|
Income/ (loss) per ADS
|
|
|
|
|
|
|
|
Basic
|
|
0.10
|
|
(0.01
|
)
|
(0.14
|
)
|
Diluted
|
|
0.10
|
|
(0.01
|
)
|
(0.14
|
)
|
|
|
|
|
|
|
|
|
Weighted average number of ordinary shares outstanding
|
|
|
|
|
|
|
|
Basic
|
|
118,625,664
|
|
121,877,701
|
|
146,852,718
|
|
Diluted
|
|
121,700,752
|
|
121,877,701
|
|
146,852,718
|
|
Weighted average number of ADS outstanding
|
|
|
|
|
|
|
|
Basic
|
|
29,656,416
|
|
30,469,425
|
|
36,713,179
|
|
Diluted
|
|
30,425,188
|
|
30,469,425
|
|
36,713,179
|
|
|
|
|
|
|
|
|
|
Other comprehensive income/ (loss):
|
|
|
|
|
|
|
|
Foreign currency translation adjustment
|
|
(254
|
)
|
(175
|
)
|
1,176
|
|
|
|
|
|
|
|
|
|
Comprehensive income/ (loss)
|
|
1,412
|
|
(2,015
|
)
|
(6,186
|
)
|
Comprehensive income/ (loss) attributable to non-controlling interest
|
|
(1,535
|
)
|
(1,498
|
)
|
(1,571
|
)
|
Comprehensive income/ (loss) attributable to Vimicro International Corporation
|
|
2,947
|
|
(517
|
)
|
(4,615
|
)
|
Components of share-based compensation expenses are included in the following expense captions:
|
|
|
|
|
|
|
|
R&D
|
|
(220
|
)
|
(462
|
)
|
(165
|
)
|
S&M
|
|
(40
|
)
|
(50
|
)
|
(15
|
)
|
G&A
|
|
(167
|
)
|
(560
|
)
|
(450
|
)
|
Total
|
|
(427
|
)
|
(1,072
|
)
|
(630
|
)
|
5
Reconciliations of non-GAAP results of operations measures to the nearest comparable GAAP measures (*)
(Amounts expressed in thousands of U.S. dollars, except per share data,unaudited)
|
|
Three months ended
|
|
Three months ended
|
|
Three months ended
|
|
|
|
September 30,
|
|
June 30,
|
|
September 30,
|
|
|
|
2012
|
|
2012
|
|
2011
|
|
|
|
GAAP
|
|
|
|
Non-
GAAP
|
|
GAAP
|
|
|
|
Non-
GAAP
|
|
GAAP
|
|
|
|
Non-
GAAP
|
|
|
|
Result
|
|
Adjustment
|
|
Results
|
|
Result
|
|
Adjustment
|
|
Results
|
|
Result
|
|
Adjustment
|
|
Results
|
|
Income/(loss) from continuing operations
|
|
1,482
|
|
427
|
|
1,909
|
|
(933
|
)
|
1,072
|
|
139
|
|
(5,311
|
)
|
630
|
|
(4,681
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income/(loss) attributed to Vimicro International Corporation
|
|
2,943
|
|
427
|
|
3,370
|
|
(343
|
)
|
1,072
|
|
729
|
|
(5,266
|
)
|
630
|
|
(4,636
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income/(loss) from continuing operations per ADS(**)
|
|
0.08
|
|
0.01
|
|
0.09
|
|
0.01
|
|
0.04
|
|
0.05
|
|
(0.06
|
)
|
0.01
|
|
(0.05
|
)
|
(*) The adjustment is to exclude non-cash share-based compensation for employees and non-employees.
(**) Loss per ADS refers to continuing operations
6
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
VIMICRO INTERNATIONAL CORPORATION
|
|
|
|
|
By:
|
/s/ John Zhonghan Deng
|
|
Name:
|
John Zhonghan Deng
|
|
Title:
|
Chairman and Chief Executive Officer
|
Date: November 13, 2012
7
(MM) (NASDAQ:VIMC)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
(MM) (NASDAQ:VIMC)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024